Literature DB >> 22265207

NeuroNEXT: accelerating drug development in neurology.

.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22265207     DOI: 10.1016/S1474-4422(12)70008-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  8 in total

1.  Natural history of infantile-onset spinal muscular atrophy.

Authors:  Stephen J Kolb; Christopher S Coffey; Jon W Yankey; Kristin Krosschell; W David Arnold; Seward B Rutkove; Kathryn J Swoboda; Sandra P Reyna; Ai Sakonju; Basil T Darras; Richard Shell; Nancy Kuntz; Diana Castro; Julie Parsons; Anne M Connolly; Claudia A Chiriboga; Craig McDonald; W Bryan Burnette; Klaus Werner; Mathula Thangarajh; Perry B Shieh; Erika Finanger; Merit E Cudkowicz; Michelle M McGovern; D Elizabeth McNeil; Richard Finkel; Susan T Iannaccone; Edward Kaye; Allison Kingsley; Samantha R Renusch; Vicki L McGovern; Xueqian Wang; Phillip G Zaworski; Thomas W Prior; Arthur H M Burghes; Amy Bartlett; John T Kissel
Journal:  Ann Neurol       Date:  2017-12-08       Impact factor: 10.422

2.  Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.

Authors:  Robert J Fox; Christopher S Coffey; Merit E Cudkowicz; Trevis Gleason; Andrew Goodman; Eric C Klawiter; Kazuko Matsuda; Michelle McGovern; Robin Conwit; Robert Naismith; Akshata Ashokkumar; Robert Bermel; Dixie Ecklund; Maxine Koepp; Jeffrey Long; Sneha Natarajan; Srividya Ramachandran; Thomai Skaramagas; Brenda Thornell; Jon Yankey; Mark Agius; Khurram Bashir; Bruce Cohen; Patricia Coyle; Silvia Delgado; Dana Dewitt; Angela Flores; Barbara Giesser; Myla Goldman; Burk Jubelt; Neil Lava; Sharon Lynch; Augusto Miravalle; Harold Moses; Daniel Ontaneda; Jai Perumal; Michael Racke; Pavle Repovic; Claire Riley; Christopher Severson; Shlomo Shinnar; Valerie Suski; Bianca Weinstock-Gutman; Vijayshree Yadav; Aram Zabeti
Journal:  Contemp Clin Trials       Date:  2016-08-10       Impact factor: 2.226

3.  Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.

Authors:  Christopher S Coffey; Bruce Levin; Christina Clark; Cate Timmerman; Janet Wittes; Peter Gilbert; Sara Harris
Journal:  Clin Trials       Date:  2012-12       Impact factor: 2.486

Review 4.  Meeting the Challenge: The National Cancer Institute's Central Institutional Review Board for Multi-Site Research.

Authors:  Holly A Massett; Sharon L Hampp; Jacquelyn L Goldberg; Margaret Mooney; Linda K Parreco; Lori Minasian; Mike Montello; Grace E Mishkin; Catasha Davis; Jeffrey S Abrams
Journal:  J Clin Oncol       Date:  2018-01-31       Impact factor: 44.544

5.  Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.

Authors:  Merit Cudkowicz; Marianne K Chase; Christopher S Coffey; Dixie J Ecklund; Brenda J Thornell; Codrin Lungu; Katy Mahoney; Laurie Gutmann; Jeremy M Shefner; Kevin J Staley; Michael Bosch; Eric Foster; Jeffrey D Long; Emine O Bayman; James Torner; Jon Yankey; Richard Peters; Trevis Huff; Robin A Conwit; Shlomo Shinnar; Donna Patch; Basil T Darras; Audrey Ellis; Roger J Packer; Karen S Marder; Claudia A Chiriboga; Claire Henchcliffe; Joyce Ann Moran; Blagovest Nikolov; Stewart A Factor; Carole Seeley; Steven M Greenberg; Anthony A Amato; Sara DeGregorio; Tanya Simuni; Tina Ward; John T Kissel; Stephen J Kolb; Amy Bartlett; Joseph F Quinn; Kellie Keith; Steven R Levine; Nadege Gilles; Patricia K Coyle; Jessica Lamb; Gil I Wolfe; Annemarie Crumlish; Luis Mejico; Muhammad Maaz Iqbal; James D Bowen; Caryl Tongco; Louis B Nabors; Khurram Bashir; Melanie Benge; Craig M McDonald; Erik K Henricson; Björn Oskarsson; Bruce H Dobkin; Catherine Canamar; Tracy A Glauser; Daniel Woo; Angela Molloy; Peggy Clark; Timothy L Vollmer; Alexander J Stein; Richard J Barohn; Mazen M Dimachkie; Jean-Baptiste Le Pichon; Michael G Benatar; Julie Steele; Lawrence Wechsler; Paula R Clemens; Christine Amity; Robert G Holloway; Christine Annis; Mark P Goldberg; Mariam Andersen; Susan T Iannaccone; A Gordon Smith; J Robinson Singleton; Mariana Doudova; E Clarke Haley; Mark S Quigg; Stephanie Lowenhaupt; Beth A Malow; Karen Adkins; David B Clifford; Mengesha A Teshome; Noreen Connolly
Journal:  JAMA Neurol       Date:  2020-06-01       Impact factor: 18.302

6.  Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study.

Authors:  Jane S Paulsen; Jeffrey D Long; Hans J Johnson; Elizabeth H Aylward; Christopher A Ross; Janet K Williams; Martha A Nance; Cheryl J Erwin; Holly J Westervelt; Deborah L Harrington; H Jeremy Bockholt; Ying Zhang; Elizabeth A McCusker; Edmond M Chiu; Peter K Panegyres
Journal:  Front Aging Neurosci       Date:  2014-04-22       Impact factor: 5.750

7.  Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!

Authors:  Amy Bartlett; Stephen J Kolb; Allison Kingsley; Kathryn J Swoboda; Sandra P Reyna; Ai Sakonju; Basil T Darras; Richard Shell; Nancy Kuntz; Diana Castro; Susan T Iannaccone; Julie Parsons; Anne M Connolly; Claudia A Chiriboga; Craig McDonald; W Bryan Burnette; Klaus Werner; Mathula Thangarajh; Perry B Shieh; Erika Finanger; Christopher S Coffey; Jon W Yankey; Merit E Cudkowicz; Michelle M McGovern; D Elizabeth McNeil; W David Arnold; John T Kissel
Journal:  Contemp Clin Trials Commun       Date:  2018-07-20

Review 8.  Adaptive trial designs: a review of barriers and opportunities.

Authors:  John A Kairalla; Christopher S Coffey; Mitchell A Thomann; Keith E Muller
Journal:  Trials       Date:  2012-08-23       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.